Your session is about to expire
← Back to Search
Behavioral Intervention
Behavioral Activation for Depression
N/A
Recruiting
Research Sponsored by University of Texas at Austin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age 18-25
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 5 weeks
Awards & highlights
Study Summary
This trial tests if changes in behavior can predict depression. GPS data from a smartphone is used to measure behavior and its relationship to depression.
Who is the study for?
This trial is for young adults aged 18-25 who feel persistently sad or can't enjoy things, scoring over 10 on a depression questionnaire. They must use a smartphone daily and speak English but have low scores on an activity scale. People with travel plans, agoraphobia, bipolar disorder, or severe neurodevelopmental disorders cannot join.Check my eligibility
What is being tested?
The study tests if changing what you do every day can affect feelings of depression. It uses GPS from smartphones to track where participants go and how it relates to their mood changes after trying out new behaviors designed to increase engagement in enjoyable activities.See study design
What are the potential side effects?
Since the intervention involves behavioral activation rather than medication, typical medical side effects are not expected. However, participants may experience discomfort or stress when altering their routines or using the tracking technology.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 25 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and 5 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 5 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Patient Health Questionnaire-8 Total Score over 5 Weeks
Secondary outcome measures
Change in Behavioral Activation for Depression Scale over 5 Weeks
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Brief modified behavioral activationExperimental Treatment1 Intervention
Participants randomized to the behavioral activation condition will meet with a graduate level clinician for one hour.
Group II: Measurement-only controlActive Control1 Intervention
Participants who are not randomized to the active condition will take part in a measurement-only control condition. They will participate in all portions of the study except for the in-person behavioral activation session. They will complete a baseline and fill out daily surveys.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for depression include pharmacotherapy and psychotherapy. Pharmacological treatments, such as selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs), work by increasing the levels of neurotransmitters like serotonin and norepinephrine in the brain, which helps improve mood and emotional stability.
Psychotherapies, such as cognitive-behavioral therapy (CBT) and mindfulness-based cognitive therapy (MBCT), focus on changing negative thought patterns and increasing awareness of the present moment, respectively. These treatments are crucial for depression patients as they address both the chemical imbalances and cognitive distortions that contribute to depressive symptoms.
Understanding the correlation between behavioral patterns, as monitored via GPS, and depression can help tailor these treatments more effectively to individual needs.
Bulimia nervosa : a review of therapy research.Comparative studies on the efficacy of psychotherapy, pharmacotherapy, and their combination in depression: was adequate pharmacotherapy provided?
Bulimia nervosa : a review of therapy research.Comparative studies on the efficacy of psychotherapy, pharmacotherapy, and their combination in depression: was adequate pharmacotherapy provided?
Find a Location
Who is running the clinical trial?
University of Texas at AustinLead Sponsor
357 Previous Clinical Trials
81,353 Total Patients Enrolled
31 Trials studying Depression
5,189 Patients Enrolled for Depression
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with agoraphobia or bipolar disorder.You have a serious developmental disorder affecting your nervous system.I do not have major travel plans during the study period.I am between 18 and 25 years old.I can follow all the steps required in the study.Your Patient Health Questionnaire-8 score is higher than 10, indicating possible depression.You possess and employ a smartphone on a regular basis.You are capable of both verbal and written English.You have a BADS Activation Subscale score of less than 16.
Research Study Groups:
This trial has the following groups:- Group 1: Brief modified behavioral activation
- Group 2: Measurement-only control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger